Browse
Submit Data
Databases
API
Help

Dataset Information

24 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bis{2-[4-(methyl-sulfan-yl)phen-yl]-1H-benzimidazol-3-ium} tetra-bromido-cuprate(II) dihydrate.

ABSTRACT: The asymmetric unit of the title compound, (C(14)H(13)N(2)S)(2)[CuBr(4)]·2H(2)O, contains two cations, one anion and two solvent water mol-ecules that are connected via O-H?Br, N-H?Br and N-H?O hydrogen bonds into a two-dimensional polymeric structure. The cations are arranged in a head-to-tail fashion and form stacks along [100]. The central Cu(II) atom of the anion is in a distorted tetra-hedral environment.

SUBMITTER: Manjunatha MN

PROVIDER: S-EPMC3089137 | biostudies-literature | 2011 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Bis{2-[4-(methyl-sulfan-yl)phen-yl]-1H-benzimidazol-3-ium} tetra-bromido-cuprate(II) dihydrate.

Manjunatha M N MN Ziaulla Mohamed M Sankolli Ravish R Begum Noor Shahina NS Nagasundara K R KR

Acta crystallographica. Section E, Structure reports online 20110413 Pt 5

The asymmetric unit of the title compound, (C(14)H(13)N(2)S)(2)[CuBr(4)]·2H(2)O, contains two cations, one anion and two solvent water mol-ecules that are connected via O-H⋯Br, N-H⋯Br and N-H⋯O hydrogen bonds into a two-dimensional polymeric structure. The cations are arranged in a head-to-tail fashion and form stacks along [100]. The central Cu(II) atom of the anion is in a distorted tetra-hedral environment. ...[more]

PMID: 21754304

Similar Datasets

Bis{2-[4-(methyl-sulfan-yl)phen-yl]-1H-benzimidazol-3-ium} tetra-bromido-cadmate(II) ethanol monosolvate.

Project description:In the anion of the title compound, (C(14)H(13)N(2)S)(2)[CdBr(4)]·C(2)H(5)OH, the Cd(II) atom is in a distorted tetra-hedral environment and one of the Br atoms is disordered over three sites with site-occupancy factors of 0.828?(5), 0.106?(3) and 0.068?(4). In the crystal, inter-molecular N-H?O, C-H?O and N-H?Br inter-actions result in a two-dimensional polymeric network extending parallel to (010).

| S-EPMC3120599 | biostudies-literature

Bis(2-trifluoro-methyl-1H-benzimidazol-3-ium) tetra-chloridomercurate dihydrate.

Project description:In the title compound, (C(8)H(6)F(3)N(2))(2)[HgCl(4)]·2H(2)O, the Hg(II) cation is coordinated by four Cl(-) anions in a distorted tetra-hedral geometry. In the crystal, the 2-trifluoro-methyl-1H-benzimidazolium cations link to the [HgCl(4)](2-) complex anions and lattice water mol-ecules via N-H?Cl and N-H?O hydrogen bonds, and the lattice water mol-ecules further link to the Hg complex anion and the organic cations via O-H?Cl and O-H?F hydrogen bonding. One of the trifluoro-methyl groups is disordered over two orientations in a 0.59?(4):0.41?(4) ratio.

| S-EPMC3379063 | biostudies-literature

1,3-Bis(pyridin-2-yl)-1H-benzimidazol-3-ium tetra-fluoridoborate.

Project description:The asymmetric unit of the title compound, C(17)H(13)N(4) (+)·BF(4) (-), contains one half of the benzimidazolium cation and one half of the tetra-fluoridoborate anion, with crystallographic mirror planes bis-ecting the mol-ecules. One F atom of the tetra-fluoridoborate is equally disordered about a crystallographic mirror plane. In the crystal, C-H?F inter-actions link the cations and anions into layers parallel to (100). The crystal packing is further stabilized by F?? contacts involving the tetra-fluoridoborate anions and the five-membered rings [F?centroid = 2.811?(2)?Å].

| S-EPMC3213512 | biostudies-literature

2-({1-[2-(Methyl-sulfan-yl)phen-yl]-1H-tetra-zol-5-yl}sulfan-yl)acetic acid.

Project description:In the title compound, C10H10N4O2S2, the tetra-zole and benzene rings are almost normal to one another, with a dihedral angle between their planes of 84.33?(9)°. In the crystal, mol-ecules are linked via pairs of bifurcated O-H?(N,N) hydrogen bonds, forming inversion dimers with graph-set motif R 4 (4)(12). The dimers are linked by significant ?-? inter-actions involving inversion-related tetra-zole rings and inversion-related benzene rings, with centroid-centroid distances of 3.7376?(14) and 3.8444?(15)?Å, respectively.

| S-EPMC3648285 | biostudies-literature

5-[4-(1H-Imidazol-1-yl)phen-yl]-2H-tetra-zole dihydrate.

Project description:In the title compound, C(10)H(8)N(6)·2H(2)O, the central aromatic ring makes dihedral angles of 23.59?(15) and 16.99?(16)° with the terminal imidazole and tetra-zole rings, respectively, which are themselves almost coplanar [dihedral angle = 6.61?(18)°]. Two H atoms of the two water mol-ecules are half occupied. In the crystal packing, weak inter-molecular O-H?N, O-H?O and N-H?N hydrogen bonds and ?-? stacking inter-actions [centroid-centroid distances of 3.73?(4)?Å between benzene rings and 3.66?(3)?Å between imidazole and tetra-zole rings] are observed.

| S-EPMC3120333 | biostudies-literature

1-(4-Carb-oxy-phen-yl)-1H-imidazol-3-ium chloride dihydrate.

Project description:In the crystal structure of the title compound, C(10)H(9)N(2)O(2) (+)·Cl(-)·2H(2)O, the components are linked by O-H?O, N-H?O, O-H?Cl and N-H?Cl hydrogen bonds. In the cation, the imidazole ring is oriented at a dihedral angle of 13.67?(17)° with respect to the benzene ring. In the crystal, ?-? stacking occurs between nearly parallel benzene rings, which are oriented at a dihedral angle of 3.4?(1)°, the centroid-centroid distance being 3.798?(3)?Å.

| S-EPMC3051584 | biostudies-literature

2-[(1H-Benzimidazol-2-yl)sulfan-yl]-1-phenyl-ethanone.

Project description:The title compound, C(15)H(12)N(2)OS, adopts a twisted V-shape, with the S atom as the pivot. The benzimidazole ring system [maximum deviation = 0.015?(1)?Å] makes a dihedral angle of 78.56?(7)° with the phenyl ring. The O atom of the ketone group is close to coplanar with its adjacent ring [O-C-C-C torsion angle = 11.0?(2)°]. In the crystal, mol-ecules are linked by N-H?N hydrogen bonds into an infinite chain along [001]. The crystal packing also features a C-H?? inter-action.

| S-EPMC3394045 | biostudies-literature

2-(2-Hy-droxy-3-meth-oxy-phen-yl)-1H-benzimidazol-3-ium perchlorate.

Project description:In the title mol-ecular salt, C(14)H(13)N(2)O(2) (+)·ClO(4) (-), the ring systems in the cation are almost coplanar [dihedral angle = 5.53?(13)°]. Intra-molecular N-H?O and O-H?O hydrogen bonds generate S(6) and S(5) rings, respectively. In the crystal, the two H atoms involved in the intra-molecular hydrogen bonds also participate in inter-molecular links to acceptor O atoms of the perchlorate anions. A simple inter-molecular N-H?O bond also occurs. Together, these form a double-chain structure along [101].

| S-EPMC3379475 | biostudies-literature

Ethane-1,2-diaminium bis-{5-[4-(1H-tetra-zol-5-yl)phen-yl]tetra-zolide} dihydrate.

Project description:In the two anions of the title salt, C(2)H(10)N(2) (2+)·2C(8)H(5)N(8) (-)·2H(2)O, the central aromatic rings make dihedral angles of 13.53?(6) and 6.53?(7)° with the deprotonated tetra-zole rings, and 11.39?(6) and 10.41?(9)° with the other tetra-zole groups. In the crystal, the cations, anions and water mol-ecules are linked by an extensive O-H?N, N-H?O and N-H?N hydrogen-bond network into two-dimensional wave-like duplex sheets extending parallel to the bc plane. ?-? stacking inter-actions between benzene rings [inter-centroid distances are 3.8482?(4) and 3.9621?(5)?Å] and between tetra-zole rings [inter-centroid distances are 3.4350?(4) and 3.7169?(4)?Å] further consolidate the crystal structure.

| S-EPMC3200657 | biostudies-literature

1-Methyl-2-({[(1-methyl-1H-benzimid-azol-2-yl)meth-yl](phen-yl)amino}-meth-yl)1H-benzimidazol-3-ium picrate.

Project description:In the title molecular salt, C(24)H(24)N(5) (+)·C(6)H(2)N(3)O(7) (-), the dihedral angle between the benzimidazole rings of the cation is 5.041?(2)°. In the anion, the three nitro groups make dihedral angles of 2.468?(3), 12.795?(3) and 24.958?(4)° with respect to the central ring. In the crystal, weak aromatic ?-? stacking [centroid-centroid distance = 3.599?(15)?Å] consolidates the packing. In addition, an intra-molecular N-H?N hydrogen bond is observed.

| S-EPMC3151771 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data